HOVON110/ReBeL Study: Results of the Phase I Part of a Randomized Phase I/II Study of Lenalidomide, Rituximab With or Without Bendamustine in Patients With Relapsed/Refractory Follicular Lymphoma

Detalles Bibliográficos
Autores principales: Stevens, Wendy B.C., Bakunina, Katerina, Cuijpers, Marloes, Chamuleau, Martine, Beeker, Aart, Fijnheer, Rob, Hebart, Holger, Visser, Hein P.J., Doorduijn, Jeanette K., Linton, Kim, Dreyling, Martin, de Jong, Daphne, Kersten, Marie José
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000479/
https://www.ncbi.nlm.nih.gov/pubmed/32072141
http://dx.doi.org/10.1097/HS9.0000000000000325

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7000479/
https://www.ncbi.nlm.nih.gov/pubmed/32072141
http://dx.doi.org/10.1097/HS9.0000000000000325

Ejemplares similares